Penumbra Inc (PEN):企業の財務・戦略的SWOT分析

【英語タイトル】Penumbra Inc (PEN) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(SWOT20MY1601)・商品コード:SWOT20MY1601
・発行会社(調査会社):GlobalData
・発行日:2020年4月
・ページ数:46
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Penumbra Inc (PEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Penumbra Inc (Penumbra) is a medical device company that designs, develops, manufactures products for neuro and vascular markets. Its products are used for various procedures of thrombectomy and embolization for treating conditions such as acute ischemic stroke, brain aneurysm, acute limb ischemia, deep vein thrombosis, neuroarteriovenous malformation, body aneurysm and others. Its major products include neurovascular access systems, revascularization device, embolization coiling system and microcatheter among others. The company sells its products to specialist physicians, hospitals and clinics through direct sales organization in the US, Canada, Australia and most of the Europe. It also distributes its products through distributors worldwide. It has operations in the US, Brazil, Germany, Australia, Canada, Singapore, France and the UK. Penumbra is headquartered in Alameda, California, the US.

Penumbra Inc Key Recent Developments

Apr 06,2020 Penumbra provides update on COVID-19 response and impact
Nov 25,2019 Maggie Yuen appointed Chief Financial Officer of Penumbra
Nov 07,2019 Penumbra reports third quarter 2019 financial results
Aug 29,2019 Sri Kosaraju promoted to President and CFO of Penumbra

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Penumbra Inc – Key Facts
Penumbra Inc – Key Employees
Penumbra Inc – Key Employee Biographies
Penumbra Inc – Major Products and Services
Penumbra Inc – History
Penumbra Inc – Company Statement
Penumbra Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Penumbra Inc – Business Description
Product Category: Neuro Products
Overview
Performance
Product Category: Vacular Products
Overview
Product Category: Vascular Products
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other International
Performance
Geographical Segment: United States
Performance
Penumbra Inc – Corporate Strategy
Penumbra Inc – SWOT Analysis
SWOT Analysis – Overview
Penumbra Inc – Strengths
Penumbra Inc – Weaknesses
Penumbra Inc – Opportunities
Penumbra Inc – Threats
Penumbra Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Penumbra Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Penumbra Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Penumbra Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 06, 2020: Penumbra provides update on COVID-19 response and impact
Nov 25, 2019: Maggie Yuen appointed Chief Financial Officer of Penumbra
Nov 07, 2019: Penumbra reports third quarter 2019 financial results
Aug 29, 2019: Sri Kosaraju promoted to President and CFO of Penumbra
Aug 06, 2019: Penumbra reports second quarter 2019 financial results
May 07, 2019: Penumbra announces first quarter 2019 financial results
Feb 26, 2019: Penumbra announces fourth quarter and full year 2018 financial results
Jan 18, 2019: Penumbra names Janet Leeds and Surbhi Sarna to its board of directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Penumbra Inc, Key Facts
Penumbra Inc, Key Employees
Penumbra Inc, Key Employee Biographies
Penumbra Inc, Major Products and Services
Penumbra Inc, History
Penumbra Inc, Subsidiaries
Penumbra Inc, Key Competitors
Penumbra Inc, Ratios based on current share price
Penumbra Inc, Annual Ratios
Penumbra Inc, Annual Ratios (Cont...1)
Penumbra Inc, Annual Ratios (Cont...2)
Penumbra Inc, Interim Ratios
Penumbra Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Penumbra Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Penumbra Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Penumbra Inc, Performance Chart (2015 - 2019)
Penumbra Inc, Ratio Charts
Penumbra Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Penumbra Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★調査レポート[Penumbra Inc (PEN):企業の財務・戦略的SWOT分析] (コード:SWOT20MY1601)販売に関する免責事項を必ずご確認ください。
★調査レポート[Penumbra Inc (PEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆